Published in Antimicrob Agents Chemother on December 28, 2006
The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance | NCT00440752
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis (2009) 2.80
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother (2009) 2.36
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malar J (2007) 2.30
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. J Infect Dis (2014) 2.28
Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg (2012) 1.97
Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. J Infect Dis (2011) 1.94
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother (2010) 1.83
Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data. Malar J (2011) 1.76
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother (2009) 1.70
Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother (2008) 1.65
Drug-resistant malaria - an insight. FEBS J (2007) 1.54
Optimum population-level use of artemisinin combination therapies: a modelling study. Lancet Glob Health (2015) 1.54
Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J (2008) 1.51
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.50
Malaria diagnostic testing and treatment practices in three different Plasmodium falciparum transmission settings in Tanzania: before and after a government policy change. Malar J (2011) 1.50
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Antimicrob Agents Chemother (2010) 1.49
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J (2007) 1.41
Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother (2010) 1.37
The interplay between drug resistance and fitness in malaria parasites. Mol Microbiol (2013) 1.35
Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother (2011) 1.32
Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis (2014) 1.29
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana. J Infect Dis (2011) 1.26
Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis (2012) 1.26
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda. Am J Trop Med Hyg (2014) 1.24
The perils of PCR: can we accurately 'correct' antimalarial trials? Trends Parasitol (2010) 1.24
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Malar J (2011) 1.20
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates. Malar J (2010) 1.20
Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola. Antimicrob Agents Chemother (2012) 1.20
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia. J Infect Dis (2010) 1.12
Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro. Antimicrob Agents Chemother (2009) 1.12
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J (2010) 1.10
Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malar J (2010) 1.10
Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi. PLoS One (2008) 1.09
Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy. Am J Trop Med Hyg (2011) 1.05
Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique. Am J Trop Med Hyg (2013) 1.04
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J (2014) 1.02
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana. Antimicrob Agents Chemother (2012) 1.02
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial. J Infect Dis (2015) 1.01
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother (2015) 1.00
Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar. Malar J (2012) 1.00
Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers. Malar J (2013) 1.00
Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum. J Clin Microbiol (2013) 0.98
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop (2011) 0.97
Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay. Antimicrob Agents Chemother (2010) 0.97
A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan. Malar J (2007) 0.96
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal. Malar J (2011) 0.95
Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan. Malar J (2013) 0.95
pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom. Antimicrob Agents Chemother (2017) 0.95
Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases? Parasitology (2011) 0.94
Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment. Parasitology (2014) 0.93
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya. PLoS One (2009) 0.92
Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy. Malar J (2014) 0.92
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network. Am J Trop Med Hyg (2015) 0.91
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin. Antimicrob Agents Chemother (2013) 0.91
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Antimicrob Agents Chemother (2014) 0.91
Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother (2014) 0.90
An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand. Sci Rep (2015) 0.90
Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname. Am J Trop Med Hyg (2013) 0.89
Fitness consequences of Plasmodium falciparum pfmdr1 polymorphisms inferred from ex vivo culture of Ugandan parasites. Antimicrob Agents Chemother (2013) 0.88
Clinical trial of extended-dose chloroquine for treatment of resistant falciparum malaria among Afghan refugees in Pakistan. Malar J (2011) 0.87
Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro. Antimicrob Agents Chemother (2012) 0.87
Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia. Malar J (2009) 0.86
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya. Int J Parasitol Drugs Drug Resist (2014) 0.85
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania. Malar J (2014) 0.85
Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure. PLoS One (2012) 0.85
Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP. PLoS One (2012) 0.84
Plasmodium falciparum drug resistance in Angola. Malar J (2016) 0.83
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia. Am J Trop Med Hyg (2012) 0.82
HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection. Antimicrob Agents Chemother (2013) 0.82
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites. J Nat Med (2016) 0.81
Alterations in Plasmodium falciparum genetic structure two years after increased malaria control efforts in western Kenya. Am J Trop Med Hyg (2012) 0.81
Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso. Malar J (2008) 0.81
Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy. Malar J (2010) 0.80
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist (2015) 0.80
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso. PLoS One (2016) 0.79
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda. Malar J (2014) 0.79
In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum. Antimicrob Agents Chemother (2015) 0.79
Alternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patients. J Antimicrob Chemother (2014) 0.79
Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola. Malar J (2015) 0.78
Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania. Malar J (2015) 0.77
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity. Antimicrob Agents Chemother (2016) 0.76
Assessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, Nigeria. PLoS One (2016) 0.76
The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa. Antimicrob Agents Chemother (2013) 0.76
The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya. Antimicrob Agents Chemother (2014) 0.76
Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagn Pathol (2015) 0.76
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model. Malar J (2015) 0.76
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model. Exp Parasitol (2009) 0.76
Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay. Antimicrob Agents Chemother (2014) 0.75
In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin. Malar J (2016) 0.75
Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether-lumefantrine treatment in Mali. Malar J (2017) 0.75
Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children. Malar J (2016) 0.75
In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity. Antimicrob Agents Chemother (2015) 0.75
Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border. Malar J (2017) 0.75
Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance. Int J Nanomedicine (2016) 0.75
Evidence of triple mutant Pfdhps ISGNGA haplotype in Plasmodium falciparum isolates from North-east India: An analysis of sulfadoxine resistant haplotype selection. Genom Data (2016) 0.75
Different patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region, Yemen. PeerJ (2016) 0.75
Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal. Malar J (2016) 0.75
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet (2004) 9.68
A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med (2001) 9.18
Intercontinental spread of pyrimethamine-resistant malaria. Science (2004) 8.73
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature (2000) 8.46
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg (2000) 7.93
Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg (1995) 7.63
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science (2002) 6.19
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis (2005) 6.13
pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol (2005) 4.92
The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother (1999) 4.64
Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci (1999) 4.52
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis (2006) 4.14
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol (2000) 4.08
Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother (2003) 4.01
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med (2005) 3.91
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother (2006) 2.74
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Genet Evol (2005) 2.22
pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol (2005) 1.76
Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am J Trop Med Hyg (2003) 1.72
Amodiaquine for treating malaria. Cochrane Database Syst Rev (2003) 1.71
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother (2004) 1.71
Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis (2005) 1.47
The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure. Am J Trop Med Hyg (2003) 1.41
Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob Agents Chemother (1999) 1.27
Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. J Postgrad Med (2004) 1.22
Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochem Pharmacol (2002) 1.12
Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A (2009) 3.30
Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans R Soc Trop Med Hyg (2002) 2.63
A ten-year follow-up of one hundred consecutive Müller curved-stem total hip-replacement arthroplasties. J Bone Joint Surg Am (1982) 2.43
D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly. Intern Med J (2007) 1.84
Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci (1998) 1.77
Ancillary-care responsibilities in observational research: two cases, two issues. Lancet (2007) 1.60
An approach to the management of paroxysmal laryngospasm. J Laryngol Otol (2007) 1.52
Evidence for a ganglion cell contribution to the primate electroretinogram (ERG): effects of TTX on the multifocal ERG in macaque. Vis Neurosci (1999) 1.50
Trichomonas vaginalis among multiethnic female UK students. Sex Transm Infect (2011) 1.39
Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex Transm Infect (2001) 1.39
Infusions of subhypnotic doses of propofol for the prevention of postoperative nausea and vomiting. Anaesthesia (1996) 1.38
A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. Infect Immun (2000) 1.36
Identifying inner retinal contributions to the human multifocal ERG. Vision Res (1999) 1.28
Sexually transmitted infections in a basic healthcare clinic in Dhaka, Bangladesh: syndromic management for cervicitis is not justified. Sex Transm Infect (1999) 1.21
Health seeking and knowledge about tuberculosis among persons with pulmonary symptoms and tuberculosis cases in Bangalore slums. Int J Tuberc Lung Dis (2008) 1.17
The effects of 2,4-dinitrophenol and other uncoupling agents on the assimilation of nitrate and nitrite by chlorella. Biochim Biophys Acta (1968) 1.14
Estimating unreported malaria cases in England: a capture-recapture study. Epidemiol Infect (2009) 1.12
Falciparum malaria in malaria-naive travellers and African visitors. QJM (2004) 1.05
The cytoadherence linked asexual gene family of Plasmodium falciparum: are there roles other than cytoadherence? Int J Parasitol (1999) 1.05
Early detection of typhoid by polymerase chain reaction. Ann Saudi Med (2007) 1.04
Bilobed oblong porous coated acetabular components in revision total hip arthroplasty. Clin Orthop Relat Res (2000) 1.03
Cutaneous larva migrans acquired in Britain. Clin Exp Dermatol (2004) 1.00
Refeeding syndrome: a literature review. Gastroenterol Res Pract (2010) 1.00
Quality of life and patient satisfaction with enhanced recovery protocols. Colorectal Dis (2010) 0.98
Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians. Clin Pharmacol Ther (1996) 0.98
Prevalence of smear-positive tuberculosis in persons aged ≥ 15 years in Bangladesh: results from a national survey, 2007-2009. Epidemiol Infect (2011) 0.98
Teaching ORT to women: individually or in groups? J Trop Med Hyg (1988) 0.97
Prolonged rubella IgM antibody response. Med J Aust (1974) 0.96
Spinal intramedullary cysticercosis in a five-year-old child: case report and review of the literature. Pediatr Infect Dis J (2001) 0.96
The detection of glaucomatous visual field defects by oculo-kinetic perimetry: which points are best for screening? Eye (Lond) (1989) 0.95
Investigation of tropical eosinophilia; assessing a strategy based on geographical area. J Infect (2003) 0.95
The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns. Malar J (2006) 0.95
Preoperative description of severe acetabular defects caused by failed total hip replacement. J Comput Assist Tomogr (1998) 0.94
Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease? Chest (1993) 0.93
Can Anaplasma ovis in small ruminants be neglected any longer? Transbound Emerg Dis (2013) 0.92
An investigation of the effects of massage on quadriceps performance after exercise fatigue. Complement Ther Nurs Midwifery (1995) 0.90
Morphine consumption in patients receiving rectal paracetamol and diclofenac alone and in combination. Br J Anaesth (1996) 0.90
An anatomical comparison of Blair and facelift incisions for parotid surgery. Clin Otolaryngol (2006) 0.90
Insights into the tobacco cessation scenario among dental graduates: an Indian perspective. Asian Pac J Cancer Prev (2012) 0.88
Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop Relat Res (1987) 0.87
Disruption of a novel open reading frame of Plasmodium falciparum chromosome 9 by subtelomeric and internal deletions can lead to loss or maintenance of cytoadherence. Mol Biochem Parasitol (1996) 0.87
Complications of proximal femoral allografts in revision total hip arthroplasty. Clin Orthop Relat Res (1993) 0.87
Population-based validation of dihydrofolate reductase gene mutations for the prediction of sulfadoxine-pyrimethamine resistance in Uganda. Trans R Soc Trop Med Hyg (2004) 0.87
MRI brain abnormalities in cochlear implant candidates: how common and how important are they? Int J Pediatr Otorhinolaryngol (2012) 0.86
Impact of El Niño and malaria on birthweight in two areas of Tanzania with different malaria transmission patterns. Int J Epidemiol (2004) 0.86
Early progressive kyphosis following compression fractures. Two case reports from a series of "stable" thoracolumbar compression fractures. Clin Orthop Relat Res (1983) 0.86
Respiratory isolation of patients with suspected pulmonary tuberculosis in an inner-city hospital. Acad Emerg Med (1997) 0.85
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Br J Clin Pharmacol (1999) 0.84
Effects of heat-stress on behavior and the pituitary adrenal axis in rats. Pharmacol Biochem Behav (1983) 0.84
Streptococcal antibodies among rural school children in Bangladesh. Bangladesh Med Res Counc Bull (2002) 0.84
The excretion of oestrogen conjugates in late pregnancy urine. J Steroid Biochem (1972) 0.84
Are intestinal helminths a risk factor for non-typhoidal Salmonella bacteraemia in adults in Africa who are seropositive for HIV? A case-control study. Ann Trop Med Parasitol (2002) 0.83
Falciparum malaria as a cause of fever in adult travellers returning to the United Kingdom: observational study of risk by geographical area. QJM (2008) 0.83
Do doctors under-provide, over-provide or do both? Exploring the quality of medical treatment in the Philippines. Int J Qual Health Care (2011) 0.83
Habituation and conditioning of the defense reactions and their cardiovascular components in cats and dogs. Pflugers Arch (1976) 0.83
Critical evaluation of computerised x ray planimetry for the measurement of lung volumes. Thorax (1995) 0.82
Influence of enhanced recovery after surgery pathways and laparoscopic surgery on health-related quality of life. Colorectal Dis (2013) 0.82
Delayed presentation of paediatric penile constrictive band injury. Br J Plast Surg (2003) 0.81
Malaria in pregnant women: research, epidemiology, policy and practice. Ann Trop Med Parasitol (1999) 0.81
The continuing risk of domestic hot water scalds to the elderly. Burns (2000) 0.80
Role of routine oesophago-gastroduodenoscopy before cholecystectomy. Int J Surg (2010) 0.80
Potential of rice husks for antimony removal. Appl Radiat Isot (2000) 0.80
A method for the determination of plasma testosterone by competitive protein-binding after chromatography on sephadex LH-20. Clin Chim Acta (1973) 0.80
Effects of adaptation level and hypoglycemia on function of the cat retina during hypoxemia. Vis Neurosci (1997) 0.79
Annual risk of tuberculous infection in Andhra Pradesh, India. Indian J Tuberc (2007) 0.79
Combination of three rapid tests: An alternative approach to confirmatory laboratory diagnosis of HIV infection in Bangladesh. Indian J Med Microbiol (2009) 0.79
Endaural meatoplasty: the Whipps Cross technique. J Laryngol Otol (2010) 0.79
Friction burns to thigh caused by tourniquet. Br J Plast Surg (1998) 0.78
Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus. Transplant Proc (2007) 0.78
Sexually transmitted infections and sexual behaviour among youth clients of hotel-based female sex workers in Dhaka, Bangladesh. Int J STD AIDS (2012) 0.78
Response of Plasmodium falciparum to chloroquine in hospital patients at Muheza, Tanzania. East Afr Med J (1985) 0.78
Coinfection of sheep with Anaplasma, Theileria and Babesia species in the Kurdistan Region, Iraq. Transbound Emerg Dis (2013) 0.78
Persistent müllerian duct syndrome: report of two boys with associated transverse testicular ectopia. J Pak Med Assoc (1999) 0.78
Monitoring of drug-resistant malaria in Africa. Lancet (2002) 0.78
Characterization of immunoglobulin E responses in Balb/c mice against the major allergens of timothy grass (Phleum pratense) pollen. Clin Exp Allergy (2003) 0.78
Serological speciation of human schistosome infections by ELISA with a panel of three antigens. J Clin Pathol (2004) 0.78
Prevalence of streptococcal sorethroat in the school children of Dhaka. Bangladesh Med Res Counc Bull (1995) 0.77
Excimer laser effects on human corneal endothelium. Modulation by serum factor(s). Arch Ophthalmol (1996) 0.77
The use of direct sequencing of dengue virus cDNA from individual field-collected Aedes aegypti for surveillance and epidemiological studies. Med Vet Entomol (2000) 0.77
Life-threatening carotid haemorrhage following blunt trauma. J Laryngol Otol (2009) 0.76
Oral rehydration therapy: a community trial comparing the acceptability of homemade sucrose and cereal-based solutions. Bull World Health Organ (1991) 0.76
Positional cloning of a sequence from the breakpoint of chromosome 9 commonly associated with the loss of cytoadherence. Ann Trop Med Parasitol (1996) 0.76
Depiction of pelvic fractures using 3D volumetric holography: comparison of plain X-ray and CT. J Comput Assist Tomogr (1996) 0.75
Oestrogen and oestrogen conjugate concentrations in late pregnancy plasma. J Steroid Biochem (1973) 0.75
WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet (2004) 0.75
Re: Superficial temporal vein graft in stapedotomy: a functional and aesthetic alternative. Clin Otolaryngol (2009) 0.75
Whole antigenic lysates of Ixodes ricinus, but not Der-p2 allergen-like protein, are potent inducers of basophil activation in previously tick-exposed human hosts. Transbound Emerg Dis (2013) 0.75
A successful twin pregnancy in a patient with HbE-β-thalassemia in western India. J Postgrad Med (2015) 0.75
Volumetric 3-D imaging of computerized tomography scans. Radiol Technol (1990) 0.75
The effects of catecholamines on circulating levels of antithrombin III in the rat. Thromb Haemost (1984) 0.75
Osteoid osteoma of the proximal femur: CT-guided preoperative localization. Orthopedics (1994) 0.75
Asymptomatic coronary artery disease detection: update 1996. A screening protocol using 16-lead high-resolution ECG, ultrafast CT, exercise testing, and radionuclear imaging. J Electrocardiol (1996) 0.75
Early and late loosening of the acetabular cup after low-friction arthroplasty. J Bone Joint Surg Am (1993) 0.75
Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders. Curr Mol Med (2016) 0.75
Special issue: Emerging and re-emerging epidemics affecting global health. Editorial. Transbound Emerg Dis (2013) 0.75
The reference value of erythrocyte sedimentation rate for differential diagnosis of rheumatic fever among Bangladeshi children. J Epidemiol (1996) 0.75
Practical application of computer-generated three-dimensional reconstructions in orthopedic surgery. Orthop Clin North Am (1986) 0.75
Erythrocyte sedimentation rate in healthy school children of Bangladesh. J Epidemiol (2000) 0.75
Managing acetabular defects. J Arthroplasty (1996) 0.75
Adaptation and validation of a portable steam sterilizer for processing intrauterine device insertion instruments and supplies in low-resource settings. Am J Infect Control (1997) 0.75